Frontlight ResearchEarly access
Trial site
David C. Pratt Cancer Center
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer2 trials
- Bladder cancer1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting1 trial
- Lead sponsor
- Pfizer2 trials
- DualityBio Inc.1 trial
- Gilead Sciences1 trial
- Janssen Research & Development, LLC1 trial
- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany1 trial
Running trials
Recruiting
Active, not recruiting
Recruiting
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
Active, not recruiting
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026